Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POINTER-HF
NCT07469722Phase 3Not yet recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Mar 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in heart failure (HF) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Pairwise Comparisons With Wins of Clinical Benefit up to 90 days. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07469722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07469722.